Ticker
INMBCompany Name
INMUNE BIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -32.2M | -64396% | $ 50K |
3/31/2025 | $ -32.71M | -65418% | $ 50K |
12/31/2024 | $ -33.36M | -238292.86% | $ 14K |
9/30/2024 | $ -25.75M | -61307.14% | $ 42K |
6/30/2024 | $ -23.03M | -27090.59% | $ 85K |
3/31/2024 | $ -18.32M | -13980.92% | $ 131K |
12/31/2023 | $ -11.98M | -7729.03% | $ 155K |
9/30/2023 | $ -14.27M | -6372.32% | $ 224K |
6/30/2023 | $ -13.38M | -4794.62% | $ 279K |
3/31/2023 | $ -14.96M | -6008.84% | $ 249K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for INMUNE BIO INC is calculated as follows: CF - Operations [ $ -6.98M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ]
Minimum
Dec 31, 2024
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 78.12% |
average | 14.35% |
median | 12.67% |
std | 21.14% |